Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 661.75M P/E 0.41 EPS this Y 35.10% Ern Qtrly Grth -
Income -73.06M Forward P/E -7.53 EPS next Y -8.30% 50D Avg Chg -
Sales 7.47M PEG -0.17 EPS past 5Y - 200D Avg Chg 16.00%
Dividend N/A Price/Book 1.22 EPS next 5Y 48.80% 52W High Chg -22.00%
Recommedations 2.50 Quick Ratio 2.59 Shares Outstanding 114.07M 52W Low Chg 58.00%
Insider Own - ROA -5.61% Shares Float 796.46M Beta 2.59
Inst Own 0.72% ROE -14.49% Shares Shorted/Prior 716.05K/806.46K Price 3.99
Gross Margin - Profit Margin - Avg. Volume 229,283 Target Price 8.00
Oper. Margin -784.65% Earnings Date - Volume 1,109,432 Change 0.00%
About Mesoblast Limited

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company offers Remestemcel-L that is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease, acute respiratory distress syndrome, and biologic refractory inflammatory bowel disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy; and MPC-25-IC for the treatment or prevention of acute myocardial infarction. It has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in Melbourne, Australia.

Mesoblast Limited News
04/25/24 Three Leading Growth Companies In Australia With Insider Ownership Reaching 27%
03/27/24 Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
01:47 PM After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
03/25/24 United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
03/13/24 Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
03/10/24 United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
03/03/24 Mesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript
02/29/24 Mesoblast First Half 2024 Earnings: EPS Beats Expectations, Revenues Lag
02/28/24 Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
07:00 AM Mesoblast Financial Results and Corporate Update Webcast
02/14/24 United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
01/30/24 Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023
01/19/24 Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
01/18/24 United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
01/08/24 Mesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years ago
01/05/24 Mesoblast Limited (MESO) Loses -5.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
12/21/23 5 Stocks to Ride the Santa Claus Rally
06:56 PM Mesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease
11/23/23 Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug
11/21/23 Mesoblast Partners With Blood and Marrow Transplant Clinical Trials Network (BMT CTN) on Pivotal Trial in Adults With SR-aGVHD
MESO Chatroom

User Image LineBacker04 Posted - 11 hours ago

$CAPR Part-1 Getting BLA-tant at this point If you haven't followed my chain of prior posts please look up what I posted in early March regarding the imminent Type-B meeting ("Rolling with the Punches" -> https://stocktwits.com/LineBacker04/message/563894298). Based on the latest information available, here are a few thoughts on what to expect going forward. 1. Change in climate at the FDA is in full force If you have followed the FDA's latest stance on approvals especially in the rare pediatric disease space (look up $SLDB, $SRPT and $MESO as examples), you will notice that the "Acceleration" part of AA is in full effect. This is leading to approvals based on smaller datasets, surrogate endpoints and bio-markers that were previously subjected to the same rigor as standard approvals. This should have been applied to HOPE-3 a while back, but with the FDA - things take time to turn around. (and things take time to revert back - which means $CAPR is sitting on a massive window of opportunity)

User Image optimal_tradus Posted - 2 days ago

$MESO why can’t this be 12$ now. Should be 1.2b market cap with a buyout of 2.5b. It will happen eventually.

User Image Aigner_Andreas Posted - 1 week ago

TD BUY $MESO at 5.01, Supp 4.69 Resis 6.59 R41 HiLo 41% T1Y 12 buy 2.4 DIV N/A #Mesoblast #stocks #trading #finance #market

User Image GurlwFatazzpurse Posted - 1 week ago

$MESO Resubmission of BLA this quarter-

User Image tkathlina Posted - 1 week ago

$MESO $MESO walking 🚶‍♀️ past VWAP positive MACD and TTM squeeze 📈📈

User Image Vic_1030 Posted - 1 week ago

$MESO wild that people do the very opposite of what the large shareholders are doing... Make it make sense If you see insiders accumulating.. Tell me why in your half a brain would you be selling... Think more than 5 mins into the future and think more like 5 years T

User Image ORIANOR Posted - 1 week ago

$MESO Traders seem to have lost patience

User Image jacckkmm Posted - 2 weeks ago

$MESO don’t forget. Few weeks ago.., Mesoblast Limited’s MESO shares surged 78.6% on Mar 26, after an encouraging regulatory update from the FDA for its lead product candidate, remestemcel-L, which is being developed for the treatment of pediatric patients with steroid-refractory acute graft versus host disease (SR-aGVHD). Soon!

User Image optimal_tradus Posted - 2 weeks ago

$MESO

User Image History101 Posted - 2 weeks ago

$SLS $SAVA $MESO $NLST $RYTM Just in case, for a brief second, in a pleasant daydream, you thought that maybe the markets are actually fair for the retailer investor... https://www.zerohedge.com/markets/scandal-rocks-bidens-labor-dept-lying-about-sharing-non-public-inflation-data-secret-group

User Image TickerDD_com Posted - 2 weeks ago

From 3/4/2024, looking back across 22 Month-Ends for MESO, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $MESO #MESO #MESOStock #TickerDD https://www.youtube.com/watch?v=OHl8LcYNPSk

User Image Builder46 Posted - 2 weeks ago

$MESO Go green 💚

User Image damnson22 Posted - 2 weeks ago

$MESO this has been darting between 5.6-6.6 is it finally over

User Image Builder46 Posted - 2 weeks ago

$MESO Insider Buying so

User Image Pharma2005 Posted - 2 weeks ago

$MESO GG keep buying. http://archive.fast-edgar.com/20240409/AV22722CLW222262222B2WY28KVR2222E262/

User Image ORIANOR Posted - 2 weeks ago

$MESO ↗️ ↗

User Image Mani86 Posted - 2 weeks ago

$MESO Another 15 million shares bought by Gregory George as per asx notice today. This is going to boom >>> go mesoblast.

User Image JuliusCoolius Posted - 2 weeks ago

$MESO it’s time to start dreaming about what this company could possibly do should they get FDA approval for the GVHD treatment in children. Could the FDA also conclude that the data is sufficient for an approval for GVHD in adults? After all, the FDA wanted them to complete a study in adults before they approved the treatment for children. Are we looking at a possible joint application for approval? What about the other viewpoint on the portfolio of treatments under development. Would that approval potentially lower the threshold for approval? All the data looks promising, from the heart data to the pain treatment data. Those could really put us in the crosshairs of some big players. Finally, what do we see happening with the stock? Do we see a scenario where the company is sold early? Do we see them taking on a commercial partner (but not sold)? Do we see them going it alone? Long termers, share your thoughts. I know you are out there.

User Image damnson22 Posted - 2 weeks ago

$MESO would love a re entry below $6

User Image Builder46 Posted - 2 weeks ago

$MESO can we get some green movement before closing $7

User Image Vic_1030 Posted - 2 weeks ago

$MESO What cracks me up...seeing folks here with a couple hundred/thousand bucks thinking their dollars move the markets ...lol If I spent my days tracking you guys I'd be broke. No conviction... No critical thinking.. Just manic movements from stock to stock Such a terrible way to live

User Image History101 Posted - 2 weeks ago

$DXYZ $SLS $DXYZ $MESO my three largest holdings, loving life today!! GLTALs!!

User Image Builder46 Posted - 2 weeks ago

$MESO “Hold” and a consensus target price of $13.67. from Ticker Report 9 days ago news

User Image jacckkmm Posted - 2 weeks ago

$MESO let’s not forget that on March 26 we learned…. Mesoblast reports FDA notification that MSB-GVHD001 data appears sufficient!!

User Image jacckkmm Posted - 2 weeks ago

$MESO we will break $8 this week. Totally agree .. no reason not too!

User Image Builder46 Posted - 2 weeks ago

$MESO Should go above last week's top up towards $8

User Image jacckkmm Posted - 2 weeks ago

$MESO $7 by 4 Pm. Picking up steam… it’s ecliptic!! lol

User Image damnson22 Posted - 2 weeks ago

$MESO wow

User Image jacckkmm Posted - 2 weeks ago

$MESO wow. On fire… word is getting out on this hidden gem! Oh yeah…

User Image jacckkmm Posted - 2 weeks ago

$ARQT and $meso. My daily double looks strong today and for this week!! Love it!